MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1867553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Xi Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Lithocholic Acid, Colitis, MicroRNAs, Gastrointestinal Microbiome. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gut microbiota, bile acid metabolism, and their derived metabolites are critical regulators of intestinal inflammation in inflammatory bowel disease (IBD). While microRNA-29a (miR-29a) is a recognized epigenetic regulator of intestinal inflammation, its role in shaping microbiota-driven bile acid metabolism, particularly secondary bile acid production, remains unclear. This study aimed to investigate how miR-29a regulates microbiota-bile acid axis, with an emphasis on lithocholic acid (LCA) and its anti-inflammatory effects in colitis.
Methods
Colitis was induced in wild-type and Mir29a/Mir29b-1 locus-deficient mice using dextran sulfate sodium (DSS), and disease severity, colonic injury, and inflammatory responses were assessed. Fecal microbiota composition and bile acid profiles were characterized using 16S rRNA gene sequencing and targeted metabolomics. Alterations in bile acids were further examined in relation to disease severity. In vitro , Caco-2 cells were used to evaluate the anti-inflammatory effects of LCA under modulation of miR-29a expression.
Results
MiR-29a/b1 deficiency significantly exacerbated DSS-induced disease severity, colonic injury, inflammatory responses, and epithelial ultrastructural damage. KO-DSS mice exhibited gut microbiota dysbiosis, with reduced microbial diversity and altered community structure. Targeted metabolomics revealed impaired primary-to-secondary BA biotransformation, characterized by chenodeoxycholic acid (CDCA) accumulation and a reduced LCA/CDCA ratio. In vitro , LCA supplementation attenuated DSS-induced pro-inflammatory gene expression, whereas this protective effect was partially diminished by miR-29a inhibition.
Conclusions
These results support a role for miR-29a in maintaining gut microbial bile acid homeostasis during colitis and contributing to the epithelial anti-inflammatory response to LCA. Together, these findings link host microRNA regulation to microbiota-derived BA function and may inform future precision strategies for IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Postdoctoral Research Station, Guangzhou University of Chinese Medicine, Guangzhou, China.
- School of Traditional Chinese Medicine (TCM) and Rehabilitation Science, Guangdong Chaozhou Health Vocational College, Chaozhou, China.
- Wingngaiyuen Chinese Medicine Clinic, Hong Kong, Hong Kong SAR, China.
- Department of Oncology, The Affiliated Traditional Chinese Medicine (TCM) Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
- Department of Breast, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Xiao, X., Gong, Q., Zheng, X., Zhou, J., Shao, C., Zuo, Q., & Cai, C. (2026). MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1867553
Vancouver
Xiao X, Gong Q, Zheng X, Zhou J, Shao C, Zuo Q, et al. MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1867553
BibTeX
@article{Xiao2026,
author = {Xiao, Xi and Gong, Qian and Zheng, Xuexia and Zhou, Junhao and Shao, Cui and Zuo, Qian and Cai, Chenhao},
title = {MiR-29a deficiency disrupts gut microbiota-bile acid homeostasis and impairs the anti-inflammatory effects of lithocholic acid in colitis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1867553}
}
EUVIMED